We developedquantitativeimmunoenzymometricassaysfor human IgG and its subclassesby usingmonoclonalantibodies, an avidin-biotin detectionsystem and, as the calibrant, the U.S. NationalReference Preparationfor SpecificHuman Proteins.The assays are sensitive (detectingas little as 6 /L), precise (average inter-assay CV <11%), and vary linearly with concentrationsover a five-to 10-fold range, depending on the monoclonal antibody. We evaluated 22 different monoclonal antibodies, many of which remained highlyreactivewhen immobilizedin wells of microtiterplates coated with bovine serum albumin-glutaraldehydeto "capture" total IgG or subclasses of lgG in the sample. We demonstratedthe specificityof the most reactive antibodies by usinga panel of 20 purifiedmyelomaproteins.The sum of lgG subclass concentrationscorrelated well (r = 0.84, p <0.001) with the total lgG measured in sera from 63 apparently healthy adults (26 men, 37 women). We estimated 95 percentile reference intervals for the immunoglobulinsin these subjectsand determinedthe followingmean percentage distributionsof lgG subclasses:IgGi 49, lgG2 33, IgG3 9, and lgG4 7. The availability of these assays should facilitatestudiesof the clinicalsignificanceof the subclasses. have been used to quantify the subclasses. For example, the non-standardized materials used to calibrate the assays have ranged from "purified" myeloma proteins to pooled human sera (2-4). Furthermore, many studies have involved use of polyclonal antibodies to the subclasses; not only are these antisera weakly reactive, they are also difficult to prepare and to standardize from batch to batch. In contrast, monoclonal antibodies, the products of stable hybridoma clones, provide a source of consistently specific and avid immunochemical reagents. Here we describe immunoenzymometric assays (EIA) for quantifying human IgG and its subclasses through the use of a panel of previously characterized monoclonal antibodies (9) immobilized on a solid-phase surface for reaction with antigen in solution.4 Using the U.S. National Reference Preparation for Specific Human Serum Proteins (USNRP) as the calibrant, we have measured the concentration of IgG and that of each subclass in 63 normal adult sera to estimate normal reference intervals. 
Materials and Methods5
Chemicals and prepared reagents. Polyoxyethylenesorbitan monolaurate , anhydrous citric acid, o-phenylenediamine, glutaraldehyde (grade II, 250 g/L aqueous solution), and bovine serum albumin (BSA; 98-99% pure, cat. no. 7030) were obtained from Sigma Chemical Co., St. Louis, MO 63178. Other reagents, including hydrogen peroxide, 300 mLIL solution, and coned. H2S04 were analyticalgrade products from Mallinckrodt, Inc., Paris, KY 40361. Normal mouse serum was purchased from Cappel Laboratories, Cochranville,
PA 19330.

Prepared reagents
were (a) phosphate-buffered saline (PBS) containing, per liter, 10 mmol of sodium phosphate and 150 mmol of NaC1, pH 7.2; (b) peroxidase substrate, per liter, 3.5 mmol of H2O2, 2.3 mmol of o-phenylenediamine, 50 mmol of citric acid, and 100 mmol of disodium phosphate, pH 5; (c) glutaraldehyde, 2 mL/L of PBS; and (d) BSA, 0.2 g/L in water and 0.5 g#{237} in PBS. We used glass-distilled water throughout the analyses.
Immunochemical reagents. Preparations of affmity-purifled biotinylated goat antiserum to human IgG, avidun, and biotinylated horseradish peroxidase (EC 1.11.1.7) were obtained as components of a kit for determining human IgO ["Vectastaun ABC" (avidin-biotinylated peroxidase complex); Vector Laboratories, Burlingame,
CA 94010].
Monoclond antibody reagents.
These mouse hybridoma products have been characterized earlier (9). After additional preliminary testing of 22 monoclonal antibodies for use in the assay (see Table 1 below), we selected five of them: HP6012 (anti-IgGi), HP6014 (anti-IgG2), HP6048 (antiIgG3), HP6022 (anti-IgG4), and HP6046 (anti-IgG). Filtered ascitic fluid that had been lyophilized in 0.2-mL borosilicate glass vaccine vials were rehydrated in distilled water, then either diluted 300-fold in PBS for immediate use in tests or dispensed in 66-1zL aliquots into polypropylene microcentrifuge tubes and stored at -40 #{176}C.
tions accompanying the product, the concentrations (g/L) of analytes in this material are: IgG 11.4, IgGi 6.95, IgG2 3.15, IgG3 0.70, and IgG4 0.61. Aliquots of the rehydrated preparation were stored at -70 #{176}C, until the day of the assay, when they were diluted 1000-, 10 000-, and 100000-fold in PBS, yielding total IgG concentrations of 11.4 mg/L, 1140 g/L, and 114 jigfL, respectively, depending on the assay. These standards were then further diluted to obtain the following range of working standard concentrations (ug/ L): IgGi, Sera. Samples were obtained, with informed consent, from 63 American Red Cross blood donors (37 women and 26 men, ages 22 to 66 years). Sera were stored at -70 #{176}C until the day before the assay, when they were thawed and kept at 4#{176}C until analysis. Samples were diluted in PBS analogously to the preparation of USNRP dilutions. For each immunoglobulin assay, we tested each sample at three different dilutions, such that the range of concentrations obtained were expected to yield absorbances overlapping the linear portion of the appropriate standard curve.
Supplies and apparatus.
Polystyrene flat-bottom 96-well microtiter plates, a "Titertek" Multiwash automatic plate washer, a "Titertek" Multiscan ifiter-photometer plate reader, and "Titertek" fixed-volume (0.1-mL) multichannel pipettes were all obtained from Flow Laboratories, Inc., McLean, VA 22102. Micropipettes and automatic diluters were from SMI, Emeryville, CA 94608, and Micromedic Systems, Huntsville, AL 35810, respectively.
Immunoassay
protocol. We coated microtiter plate wells with BSA-glutaraldehyde as described by Saunders (13). Briefly, the procedure is as follows. Allow 20 zg of BSA in 0.1 mL of distilled water to air-dry in each well at 37 #{176}C, then add 0.1 mL of 2 milL glutaraldehyde solution (pH 7.2, verified) and let sit for 30 mm at 37 #{176}C. Wash the plates by machine five times with distilled water, allow to air-dry at 37#{176}C, then store in sealed plastic envelopes in a desiccator at room temperature for no longer than six months. Optimal reaction conditions had been determined in preliminary experiments.
All reagents and samples were added to the wells in 0.1-mL volumes. After each step in the procedure, plates were washed by machine five times with PBS containing 0.5 mL of Tween-20 per liter, unless otherwise stated. Drying and incubation steps were done at 37 #{176}C, unless otherwise stated.
Every assay plate included four or five dilutions of USNRP for the calibration curves, background reaction wells (with only the sample omitted), and dilutions of a sample of pooled human sera for monitoring reproducibility. All reactions were performed in quadruplicate.
The selected monoclonal antibodies, still in ascitic fluid and unpurified, were conjugated to precoated BSA-glutaraldehyde microtiter plates by diluting the antibodies 300-fold and letting them react until the plates were completely dry, typically 20-24 h. We then added BSA (50 .tg in 0. We prepared the avidin-biotinylated peroxidase complex reagent ("Vectastain ABC") by first diluting it 100-fold in PBS at room temperature 30 mm before use; just before use, we further diluted it 40-fold in PBS and let it react with the samples on the plate for 45 mm. We then added peroxidase substrate to the wells and incubated with continuous mixing in a water bath at 23 ± 2#{176}C for 8 mm. The reaction was stopped by adding H2S04, 2.5 mol/L. We measured the absorbance of the chromogen at 492 nm.
Data reduction and analysis.
Standard dose-response curves were constructed from averaged absorbance values and concentrations that had been entered into a curvefitting four-parameter logistic program, available in a desktop computer software package from the Corning Inform Diagnostics ifi Data Management System (Corning Medical and ScientifIc, Medfleld, MA 02052). The mathematical model has been described elsewhere (14). The concentration of each analyte in each sample was obtained by interpolating the averaged absorbance value from the standard curve and multiplying the result by the dilution factor; only values from the linear portions of the curves were considered valid.
We used linear regression analysis to estimate the relationship between the IgG subclasses and IgG, and to compare total IgG as measured with a monoclonal antibody vs the total IgG calculated as the sum of IgG subclass measurements. Decisions for significance were based on the F-test. We used the two-sample Student's t-test at the 0.05 probability level to estimate the significance of sex-related differences of the immunoglobulin concentrations. For all statistical tests we used the ABSTAT programs (Anderson-Bell, Denver, CO 80236) in an Altos-8000 microcomputer (Altos, San Jose, CA 95134).
Results
Reactivity and Specificity of Monoclonal Antibodies
We evaluated 22 unpurified monoclonal antibodies (in ascitic fluid) that are known to react with various portions of human IgG or IgG subclasses in order to determine their reactivity as capture antibodies (Table 1) . Although two of the anti-IgGi antibodies, HP6001 and HP6012, had reacted strongly in an immunofluorometric assay against solidphase antigens (9), only HP6012 reacted as a capture antibody in this EIA against antigen in solution. Similarly, the reactivity of the anti-IgG2 and anti-IgG4 as capture antibodies ranged widely: anti-IgG2 HP6014 was strongly reactive, but anti-IgG2 HP6002 was unreactive. Of the antiIgG4 hybridoma products, three reacted well, four reacted moderately well, and two did not react as EIA capture antibodies. Both anti-IgG3 antibodies and all four anti-IgG antibodies performed well. For subsequent studies, we selected the most reactive monoclonal antibody in each group: anti-IgGl, HP6012; anti-IgG2, HP6O14; anti-IgG3, 11P6048; anti-IgG4, HP6022; and anti-IgG, HP6046.
We confirmed the specificity of the selected monoclonal antibodies in this assay configuration by using a panel of 20 purified IgG myeloma proteins (Figure 1) (Figure 1) are almost certainly attributable to the presence of non-paraprotein IgG, because we did not attempt to eliminate these from our preparations of the myeloma proteins.
Standard Curves
Representative standard curves for the five assays, constructed point-to-point before computer transformation, are shown in Figure 2 Table 2 summarizes the inter-and intra-assay precision determined with pooled human sera. The between-assay CV, averaged for the five tests, was 10.8%; the average within-assay CV was 2.6%.
Precision
Correlation between Measured and Calculated Total lgG in Normal Sera
We quantified the four IgG subclasses and total IgG in 63 healthy adult sera. Between assays (n = 14)
Mean,g/L Finally, we calculated the mean percentage of each subclass
Human sara from 50 sub3ectswere pooled and stored at -70 'C insinglein the sera.
use aliquots. Onassay days, quadruplicate measurementsofthepooledsera were performed in parallel with the testedsera. The between-assay values were obtained on 14 different daysduringsix weeks; the within-assay data were all obtained onone day. Development of these assays required us to confront several problems that have limited both clinical and research applications of IgG-subclass measurements. Five tions of total IgG and subclasses for our sample of the well-characterized monoclonal antibodies to human IgO normal population (Figure 4) . The sex-related differences heavy-chain epitopes (9) have been adapted to a solid-phase 1.0 (Figure 3) , there was also a slight positive bias. children (3,19,20) .
The percent-7(07) age subclass distributions that we found are similar to those from two large studies of adults; these studies used polyclonal antisera and different calibrators and assay procedures (2, 3) . We found a slightly lower mean percentage of IgGl (49%), higher IgG3 (9%) and IgG4 (7%), and a similar IgG2 percentage (33%) as compared with those previously reported [Morrell and Skvaril (2) : IgGi, 61%; IgG2, 30%; IgG3, 5%; IgG4, 4%; van der Geissen et al. (3): IgGi, 58%; IgG2, 31%; IgG3, 5%; IgG4, 5%]. These differences may reflect the use of different antibodies, calibrators, or methods, or intrinsic differences in the subjects studied, or both. Our use of the USNRP eliminates at least one of these variables and allows comparison among subsequent studies in which this same calibrator is used.
The normal reference interval for total IgG and IgGl, IgG2, and IgG3 spanned approximately one order of magnitude, while that for IgG4 spanned approximately two orders of magnitude.
Since our detection limit for IgG4 is 6 .og/L, approximately one order of magnitude lower than in several other studies (3, 21-23), and the coefficient of variation of our IgG4 assay is comparable with that for the other subclasses, this broad range may reflect greater biological variation in the immunogenetics or immunoregulation of this subclass.
These precise immunoassays should facilitate studies of the clinical significance of IgG subclasses. Fifty microliters of serum is sufficient to complete all five iminunoglobulin tests. This micro-sample volume requirement, stemming from the assay sensitivity, is especially desirable for testing sera from children. In addition, such samples as bronchoalveolar lavage fluid and cell culture supernates, which contain very low concentrations of IgG, may be assayed.
